Pharmacologically, nicotine is primarily classified as a CNS stimulant, not a depressant. The WHO and ICD-11 classification list nicotine alongside caffeine as stimulant psychoactive substances. Within seconds of inhalation, nicotine crosses the blood-brain barrier, binds to nicotinic acetylcholine receptors, triggers dopamine release in the ventral tegmental area and noradrenaline release from the sympathetic nervous system. The result: increased heart rate, blood pressure, alertness and focus. These are all stimulant effects.

However, nicotine is unusual in that its profile changes from stimulant to sedative with increasing dosages, a phenomenon known as “Nesbitt’s paradox” after the doctor who first described it in 1969. At low to moderate doses (typical vape sessions), nicotine acts as a stimulant. At very high doses (heavy chronic use, especially multiple devices in quick succession), it can dampen neuronal activity and produce sedative-like effects. This dose-dependent dual action is unusual among stimulants. Nicotine also induces both behavioural stimulation and anxiety in animal models, depending on dose.

The “relaxation” that most chronic vapers and smokers report feeling from nicotine use is not true depressant action. It is the relief from withdrawal symptoms (irritability, anxiety, restlessness) that had been building up between sessions. Most chronic users are constantly cycling between mild withdrawal (anxious, tense) and brief relief (calm) after each vape. The brain interprets this relief as “relaxation” but it is actually a return to baseline from below-baseline withdrawal. This is why long-term nicotine use actually worsens depression and anxiety rather than treating them. UK Royal College of Psychiatrists and NHS mental health guidance: nicotine should not be used as anxiety or depression management; evidence-based treatment (therapy, medication, lifestyle modification) addresses these conditions better.

Nesbitt’s paradox explained: how nicotine becomes “depressant-like”

In 1969, Dr Nesbitt first described that smokers often report feeling calmer after smoking despite nicotine being a stimulant. The paradox’s resolution involves several mechanisms. First, dose-response: nicotine acts on multiple nicotinic acetylcholine receptor (nAChR) subtypes, each with different functions. Low doses preferentially activate alpha-4 beta-2 receptors (stimulant effects). High doses begin to desensitise these receptors and activate alpha-7 receptors that have inhibitory effects in some pathways. Second, biphasic timing: each nicotine session has an initial stimulant phase (1-5 minutes after inhalation) followed by a depressant-like phase (5-30 minutes after) as the brain rebalances. Third, withdrawal relief: as detailed above, most chronic users feel withdrawal-relief calmness rather than true sedation. Fourth, behavioural conditioning: the act of pausing for a vape session itself promotes relaxation through ritual, deep breathing, brief mental break – effects that have nothing to do with nicotine’s pharmacology. Nesbitt’s paradox is now well-established in pharmacology textbooks but the key insight remains: nicotine is primarily a stimulant; its apparent depressant effects in chronic users are mostly explained by withdrawal cycling rather than true sedative action.

Why nicotine worsens depression and anxiety long-term despite acute relief

Three mechanisms explain why nicotine harms mental health long-term. First, withdrawal-cycling stress. Chronic users experience multiple daily withdrawal cycles (each 30-60 minutes between vape sessions). Each withdrawal triggers anxiety, irritability, tension. The cumulative stress load over months and years contributes to baseline anxiety elevation and depression risk. Second, neurotransmitter depletion. Chronic nicotine use upregulates nicotinic receptors and depletes baseline dopamine, serotonin and noradrenaline reserves. Without nicotine stimulation, mood is below pre-use baseline. The brain becomes dependent on nicotine just to feel “normal.” Third, sleep disruption. Nicotine suppresses REM and deep sleep. Poor sleep is among the strongest predictors of depression and anxiety. Chronic vapers sleep-deprived chronically have worse mental health. UK research consistently shows: smokers and vapers have 2-3x higher rates of depression and anxiety than never-users; ex-users’ mental health typically improves within 3-6 months of cessation; teens who start vape or smoke have higher rates of subsequent mental health diagnoses than peers. UK NHS mental health guidance: address nicotine dependency as part of mental health treatment, not as a self-medication strategy.

Practical mental health guidance for UK vapers

Six-point framework. First, do not use vape to manage anxiety or depression. The relief is withdrawal cycling, not true treatment. NHS evidence-based treatments work better. Second, see GP about persistent low mood or anxiety. NHS pathways: SSRI/SNRI medication, CBT (cognitive behavioural therapy), IAPT (Improving Access to Psychological Therapies) self-referral. Free at point of use. Third, recognise the withdrawal-cycling pattern. If you feel “calm” after vape and “tense” between sessions, that is withdrawal cycling not relaxation. Fourth, consider vape cessation with NHS Stop Smoking support. Most ex-users report improved mental health within 3-6 months. Quadruple quit success with behavioural support plus NRT or vape stepdown. Fifth, address sleep. No vape within 4 hours of bedtime. Sleep is the foundation of mental health. Sixth, evidence-based stress management: regular exercise (150 min/week NHS guidance), meditation/mindfulness, social connection, work-life boundaries. None require nicotine. UK Royal College of Psychiatrists position: nicotine dependence is a mental health condition itself; addressing it improves other mental health outcomes.

For UK vapers concerned about mental health, the four-step framework below reflects NHS and Royal College of Psychiatrists guidance.

For UK adults experiencing mental health crisis or significant depression/anxiety, contact NHS Samaritans (116 123, free 24/7) or your GP urgently. Mental health services are available NHS-free at point of use. Be honest about vape use when discussing mental health; nicotine dependence is itself a mental health condition and addressing it improves other outcomes. Our Omagh and Strabane teams can advise on stepdown protocols if you are planning vape cessation as part of mental health improvement.